We provide 1 form of Irinotecan
Irinotecan hydrochloirde
100286-90-6
|
623.139
|
2.728
Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. It is a derivative of camptothecin that inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex, and causes double-strand DNA breakage and cell death.
CPT-11 | Campto | camptosar | irinotecan | irinotecan Hydrochloride | irinotecan hydrochloirde | irinotecan monohydrochloride
Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. It is a derivative of camptothecin that inhibits the action of topoisomerase I. Irinotecan prevents religation of the DNA strand by binding to topoisomerase I-DNA complex, and causes double-strand DNA breakage and cell death.
CPT-11 | Campto | camptosar | irinotecan | irinotecan Hydrochloride | irinotecan hydrochloirde | irinotecan monohydrochloride
$43/5 mg
(EBC)
1
We provide 2 compounds for Irinotecan
Irinotecan Related Compound B
(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
SN-38
86639-52-3
392.405
1.974
$19/5 mg
(EBC)
1
Irinotecan Related Compound A
(19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
(S)-10-Hydroxycamptothecin
19685-09-7
364.106
0.946
$19/5 mg
(EBC)
1